Inhibition of APOC3, similar to the decrease in Apo-B level, was significantly correlated with an increased IPF risk (OR = 1.42, 95% CI: 1.20 – 1.67, P = 3.17 × 10–5). This evidence concerns the gene APOC3 and idiopathic pulmonary fibrosis.